https://www.globenewswire.com/news-release/2021/11/15/2334457/0/en/Zenith-and-Newsoara-Biopharma-Announce-Expanded-Licensing-and-Investment.html
So, why give it away at this price when:
1. You're at the advanced stage of development that you are with ZEN-3694?
2. You are expecting some jaw-dropping numbers over at Resverlogix with regards to the Covid-19 trial?
Again...not adding up!